Rafael Holdings, Inc

RFLNYSE · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

No share count on file in the XBRL facts for this window.

Newest

$25.0M

S-3 of 2025-04-18. 1 prospectus supplement filed under it since. S-3 ↗

1 of its filings are not read yet.

Warrants

645K

Warrants of every class as tagged in the XBRL facts on 2026-04-30. 10-Q ↗

Cash

3.8 quarters

$30.5M on 2026-04-30 ÷ $8.0M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised: 2 of its filings are not read yet.